Crystallography Open Database

Result: there are 271 entries in the selection

Switch to the old layout of the page

Download all results as: list of COD numbers | list of CIF URLs | data in CSV format | archive of CIF files (ZIP)

Searching journal of publication like 'Journal of medicinal chemistry'

Left arrow Left arrow First | Left arrow Previous 100 | of 3 | Next 100 Blue right arrow | Last Blue right arrow Blue right arrow | Display 5 20 50 100 200 300 500 1000 entries per page

COD ID Blue up arrow Links Formula Up arrow Space group Up arrow Cell parameters Cell volume Up arrow Bibliography
1501660 CIFC26 H26 N2 O2P 21 21 2111.2339; 11.6808; 16.4783
90; 90; 90
2162.3Trapella, Claudio; Pela, Michela; Del Zoppo, Luisa; Calo, Girolamo; Camarda, Valeria; Ruzza, Chiara; Cavazzini, Alberto; Costa, Valentina; Bertolasi, Valerio; Reinscheid, Rainer K.; Salvadori, Severo; Guerrini, Remo
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68).
Journal of medicinal chemistry, 2011, 54, 2738-2744
1501661 CIFC46 H36 Br4 N2 O7P 21 21 218.6598; 21.3183; 23.6397
90; 90; 90
4364.2Magedov, Igor V.; Frolova, Liliya; Manpadi, Madhuri; Bhoga, Uma devi; Tang, Hong; Evdokimov, Nikolai M.; George, Olivia; Georgiou, Kathy Hadje; Renner, Steffen; Getlik, Matthäus; Kinnibrugh, Tiffany L.; Fernandes, Manuel A.; Van slambrouck, Severine; Steelant, Wim F. A.; Shuster, Charles B.; Rogelj, Snezna; van Otterlo, Willem A. L.; Kornienko, Alexander
Anticancer properties of an important drug lead podophyllotoxin can be efficiently mimicked by diverse heterocyclic scaffolds accessible via one-step synthesis.
Journal of medicinal chemistry, 2011, 54, 4234-4246
1501662 CIFC18 H18 N4 O4 SP 1 21/n 113.6739; 17.3161; 14.9225
90; 98.051; 90
3498.5Hall, Matthew D.; Brimacombe, Kyle R.; Varonka, Matthew S.; Pluchino, Kristen M.; Monda, Julie K.; Li, Jiayang; Walsh, Martin J.; Boxer, Matthew B.; Warren, Timothy H.; Fales, Henry M.; Gottesman, Michael M.
Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.
Journal of medicinal chemistry, 2011, 54, 5878-5889
1501663 CIFC16 H14 N4 O SP 1 21/c 116.7856; 5.4114; 16.1237
90; 100.73; 90
1438.97Hall, Matthew D.; Brimacombe, Kyle R.; Varonka, Matthew S.; Pluchino, Kristen M.; Monda, Julie K.; Li, Jiayang; Walsh, Martin J.; Boxer, Matthew B.; Warren, Timothy H.; Fales, Henry M.; Gottesman, Michael M.
Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.
Journal of medicinal chemistry, 2011, 54, 5878-5889
1501664 CIFC17 H24 Br N O4 SiP 21 21 216.5913; 15.0012; 20.319
90; 90; 90
2009.1Xin, Qisheng; Fan, Houxing; Guo, Bin; He, Huili; Gao, Suo; Wang, Hui; Huang, Yanqin; Yang, Yushe
Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents.
Journal of medicinal chemistry, 2011, 54, 7493-7502
1501665 CIFC18 H17 Cl2 F N4 OP 1 21/c 18.1141; 10.4273; 22.6565
90; 108.576; 90
1817.1Yu, Wenquan; Goddard, Cally; Clearfield, Elizabeth; Mills, Courtney; Xiao, Tong; Guo, Haitao; Morrey, John D.; Motter, Neil E.; Zhao, Kang; Block, Timothy M.; Cuconati, Andrea; Xu, Xiaodong
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.
Journal of medicinal chemistry, 2011, 54, 5660-5670
1501666 CIFC21 H30 F3 N O3P 21 21 218.1766; 10.4313; 23.7612
90; 90; 90
2026.65Woods, James R.; Mo, Huaping; Bieberich, Andrew A.; Alavanja, Tanja; Colby, David A.
Fluorinated amino-derivatives of the sesquiterpene lactone, parthenolide, as (19)f NMR probes in deuterium-free environments.
Journal of medicinal chemistry, 2011, 54, 7934-7941
1501667 CIFC24 H21 Cl N4 O6P -19.0566; 12.7489; 12.9111
110.172; 103.14; 105.713
1259.3Bollini, Mariela; Domaoal, Robert A.; Thakur, Vinay V.; Gallardo-Macias, Ricardo; Spasov, Krasimir A.; Anderson, Karen S.; Jorgensen, William L.
Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents.
Journal of medicinal chemistry, 2011, 54, 8582-8591
1502658 CIFC27 H23 Cl3 N4 O2P 21 21 2111.1695; 11.2252; 20.0044
90; 90; 90
2508.1Yan, Lin; Huo, Pei; Debenham, John S.; Madsen-Duggan, Christina B; Lao, Julie; Chen, Richard Z.; Xiao, Jing Chen; Shen, Chun-Pyn; Stribling, D. Sloan; Shearman, Lauren P.; Strack, Alison M.; Tsou, Nancy; Ball, Richard G.; Wang, Junying; Tong, Xinchun; Bateman, Thomas J.; Reddy, Vijay B. G.; Fong, Tung M.; Hale, Jeffrey J.
Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.
Journal of medicinal chemistry, 2010, 53, 4028-4037
1502659 CIFC17 H18 N4 O2 SP -18.187; 10.274; 11.169
116.031; 92.445; 108.955
779.2Ivachtchenko, Alexandre V.; Dmitriev, Dmitri E.; Golovina, Elena S.; Kadieva, Madina G.; Koryakova, Angela G.; Kysil, Volodymyr M.; Mitkin, Oleg D.; Okun, Ilya M.; Tkachenko, Sergey E.; Vorobiev, Anton A.
(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor.
Journal of medicinal chemistry, 2010, 53, 5186-5196
1502660 CIFC18 H20 N4 O2 SP 1 21/n 18.7051; 16.7415; 11.6695
90; 98.996; 90
1679.75Ivachtchenko, Alexandre V.; Dmitriev, Dmitri E.; Golovina, Elena S.; Kadieva, Madina G.; Koryakova, Angela G.; Kysil, Volodymyr M.; Mitkin, Oleg D.; Okun, Ilya M.; Tkachenko, Sergey E.; Vorobiev, Anton A.
(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor.
Journal of medicinal chemistry, 2010, 53, 5186-5196
1502661 CIFC48 H50 N16 Ni O11P -113.8735; 14.2569; 15.0005
106.463; 99.654; 113.031
2484.7Maldonado, Carmen R.; Marín, Clotilde; Olmo, Francisco; Huertas, Oscar; Quirós, Miguel; Sánchez-Moreno, Manuel; Rosales, María J; Salas, Juan M.
In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Journal of medicinal chemistry, 2010, 53, 6964-6972
1502662 CIFC32 H28 N14 Ni O4P -18.738; 12.35; 16.754
73.779; 75.733; 69.31
1601.9Maldonado, Carmen R.; Marín, Clotilde; Olmo, Francisco; Huertas, Oscar; Quirós, Miguel; Sánchez-Moreno, Manuel; Rosales, María J; Salas, Juan M.
In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Journal of medicinal chemistry, 2010, 53, 6964-6972
1502663 CIFC36 H28 N14 Ni O4C 1 2/c 113.226; 15.714; 16.609
90; 90.107; 90
3451.9Maldonado, Carmen R.; Marín, Clotilde; Olmo, Francisco; Huertas, Oscar; Quirós, Miguel; Sánchez-Moreno, Manuel; Rosales, María J; Salas, Juan M.
In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Journal of medicinal chemistry, 2010, 53, 6964-6972
1502664 CIFC25 H52 Gd N5 O10 SP -18.0364; 10.4906; 21.799
76.573; 86.307; 88.816
1783.8Raghunand, Natarajan; Guntle, Gerald P.; Gokhale, Vijay; Nichol, Gary S.; Mash, Eugene A.; Jagadish, Bhumasamudram
Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imaging.
Journal of medicinal chemistry, 2010, 53, 6747-6757
1502665 CIFC16 H38 Cl2 N6 O2 PtP -17.336; 8.228; 10.622
83.82; 103.76; 103.21
605.3Marzano, Cristina; Mazzega Sbovata, Silvia; Gandin, Valentina; Colavito, Davide; Del Giudice, Elda; Michelin, Rino A.; Venzo, Alfonso; Seraglia, Roberta; Benetollo, Franco; Schiavon, Mariano; Bertani, Roberta
A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
Journal of medicinal chemistry, 2010, 53, 6210-6227
1502666 CIFC19 H28 B10 OC 1 2 124.701; 6.5249; 18.081
90; 131.621; 90
2178.5Beer, Michael L.; Lemon, Jennifer; Valliant, John F.
Preparation and evaluation of carborane analogues of tamoxifen.
Journal of medicinal chemistry, 2010, 53, 8012-8020
1502667 CIFC18 H26 B10 OP 1 21/n 117.7571; 6.5335; 18.0351
90; 95.656; 90
2082.2Beer, Michael L.; Lemon, Jennifer; Valliant, John F.
Preparation and evaluation of carborane analogues of tamoxifen.
Journal of medicinal chemistry, 2010, 53, 8012-8020
1502668 CIFC16 H10 N3P 1 21/c 115.046; 9.845; 16.267
90; 98.773; 90
2381.4Tan, Caiping; Lai, Sensen; Wu, Shouhai; Hu, Sheng; Zhou, Lingjun; Chen, Yu; Wang, Minxu; Zhu, Yiping; Lian, Wu; Peng, Wenlie; Ji, Liangnian; Xu, Anlong
Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis.
Journal of medicinal chemistry, 2010, 53, 7613-7624
1502669 CIFC37 H33 F12 N7 O2 P2 RuP 1 21/c 114.756; 18.5156; 15.3421
90; 113.283; 90
3850.4Tan, Caiping; Lai, Sensen; Wu, Shouhai; Hu, Sheng; Zhou, Lingjun; Chen, Yu; Wang, Minxu; Zhu, Yiping; Lian, Wu; Peng, Wenlie; Ji, Liangnian; Xu, Anlong
Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis.
Journal of medicinal chemistry, 2010, 53, 7613-7624
1502670 CIFC26.5 H33 N O6.5P 1 21 15.1805; 17.2642; 28.104
90; 92.234; 90
2511.63Auzzas, Luciana; Larsson, Andreas; Matera, Riccardo; Baraldi, Annamaria; Deschênes-Simard, Benoît; Giannini, Giuseppe; Cabri, Walter; Battistuzzi, Gianfranco; Gallo, Grazia; Ciacci, Andrea; Vesci, Loredana; Pisano, Claudio; Hanessian, Stephen
Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity.
Journal of medicinal chemistry, 2010, 53, 8387-8399
1502671 CIFC22 H21 N3 O4C 1 2/c 117.16; 8.241; 28.64
90; 105.34; 90
3905.8Zhu, Mingyan; Kim, Myung Hee; Lee, Sanghee; Bae, Su Jung; Kim, Seong Hwan; Park, Seung Bum
Discovery of novel benzopyranyl tetracycles that act as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand.
Journal of medicinal chemistry, 2010, 53, 8760-8764
1502672 CIFC33 H52 O3P 21 21 217.2672; 11.8653; 33.6544
90; 90; 90
2901.94Genet, Cédric; Strehle, Axelle; Schmidt, Céline; Boudjelal, Geoffrey; Lobstein, Annelise; Schoonjans, Kristina; Souchet, Michel; Auwerx, Johan; Saladin, Régis; Wagner, Alain
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
Journal of medicinal chemistry, 2010, 53, 178-190
1502673 CIFC19 H27 N4 O2.5C 1 2/c 113.2127; 14.571; 37.9181
90; 94.572; 90
7276.8Vernekar, Sanjeev Kumar V.; Hallaq, Hasan Y.; Clarkson, Guy; Thompson, Andrew J.; Silvestri, Linda; Lummis, Sarah C. R.; Lochner, Martin
Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.
Journal of medicinal chemistry, 2010, 53, 2324-2328
1502674 CIFC19 H28 N4 O3P -17.3381; 10.1087; 13.655
74.375; 75.612; 70.157
903.66Vernekar, Sanjeev Kumar V.; Hallaq, Hasan Y.; Clarkson, Guy; Thompson, Andrew J.; Silvestri, Linda; Lummis, Sarah C. R.; Lochner, Martin
Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.
Journal of medicinal chemistry, 2010, 53, 2324-2328
1503454 CIFC25 H22 N2 O4P 1 21 16.2608; 27.9762; 11.5615
89.99; 90.002; 89.995
2025.04Zhang, Hankun; Tückmantel, Werner; Eaton, J. Brek; Yuen, Po-Wai; Yu, Li-Fang; Bajjuri, Krishna Mohan; Fedolak, Allison; Wang, Daguang; Ghavami, Afshin; Caldarone, Barbara; Paterson, Neil E.; Lowe, David A.; Brunner, Daniela; Lukas, Ronald J.; Kozikowski, Alan P.
Chemistry and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile.
Journal of medicinal chemistry, 2012, 55, 717-724
1503455 CIFC12 H16 Br N3 O2 SP 1 21/c 110.18411; 14.96067; 9.13052
90; 99.2862; 90
1372.9Baud, Matthias G. J.; Leiser, Thomas; Haus, Patricia; Samlal, Sharon; Wong, Ai Ching; Wood, Robert J.; Petrucci, Vanessa; Gunaratnam, Mekala; Hughes, Siobhan M.; Buluwela, Lakjaya; Turlais, Fabrice; Neidle, Stephen; Meyer-Almes, Franz-Josef; White, Andrew J. P.; Fuchter, Matthew J.
Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets.
Journal of medicinal chemistry, 2012, 55, 1731-1750
1503662 CIFC14 H13 N O3 S2P c a 2113.516; 9.108; 22.558
90; 90; 90
2777Agrawal, Arpita; de Oliveira, César Augusto F; Cheng, Yuhui; Jacobsen, Jennifer A.; McCammon, J. Andrew; Cohen, Seth M.
Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor.
Journal of medicinal chemistry, 2009, 52, 1063-1074
1503663 CIFC22 H25 N3 O3P -18.3877; 8.4043; 15.1821
100.357; 103.537; 101.37
991Diaz, Philippe; Phatak, Sharangdhar S.; Xu, Jijun; Astruc-Diaz, Fanny; Cavasotto, Claudio N.; Naguib, Mohamed
6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.
Journal of medicinal chemistry, 2009, 52, 433-444
1503664 CIFC17 H26 N2 O2P 1 21 16.6457; 10.369; 11.3174
90; 92.645; 90
779.04Fox, David J.; Reckless, Jill; Lingard, Hannah; Warren, Stuart; Grainger, David J.
Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors.
Journal of medicinal chemistry, 2009, 52, 3591-3595
1503665 CIFC14 H24 N2 O2P 21 21 2110.2116; 10.8607; 13.1256
90; 90; 90
1455.7Fox, David J.; Reckless, Jill; Lingard, Hannah; Warren, Stuart; Grainger, David J.
Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors.
Journal of medicinal chemistry, 2009, 52, 3591-3595
1503666 CIFC11 H20 N2 O2P 1 21 111.4279; 9.9784; 16.245
90; 93.967; 90
1848.01Fox, David J.; Reckless, Jill; Lingard, Hannah; Warren, Stuart; Grainger, David J.
Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors.
Journal of medicinal chemistry, 2009, 52, 3591-3595
1503667 CIFC18 H20 O5P 1 21/c 110.834; 11.623; 13.511
90; 104; 90
1650.8Messaoudi, Samir; Tréguier, Bret; Hamze, Abdallah; Provot, Olivier; Peyrat, Jean-François; De Losada, Jordi Rodrigo; Liu, Jian-Miao; Bignon, Jérôme; Wdzieczak-Bakala, Joanna; Thoret, Sylviane; Dubois, Joëlle; Brion, Jean-Daniel; Alami, Mouâd
Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent.
Journal of medicinal chemistry, 2009, 52, 4538-4542
1503668 CIFC21 H24 O6P 1 21 19.7642; 8.0842; 11.694
90; 98.007; 90
914.1Li, Zheng; Zhou, Zhao-Li; Miao, Ze-Hong; Lin, Li-Ping; Feng, Hui-Jin; Tong, Lin-Jiang; Ding, Jian; Li, Yuan-Chao
Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
Journal of medicinal chemistry, 2009, 52, 5115-5123
1503669 CIFC21 H24 O8 SP 21 21 219.8274; 11.5318; 17.6885
90; 90; 90
2004.6Li, Zheng; Zhou, Zhao-Li; Miao, Ze-Hong; Lin, Li-Ping; Feng, Hui-Jin; Tong, Lin-Jiang; Ding, Jian; Li, Yuan-Chao
Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
Journal of medicinal chemistry, 2009, 52, 5115-5123
1503670 CIFC9 H12 N4 SP -17.3747; 7.4532; 9.6324
97.192; 109.63; 95.02
489.97Kowol, Christian R.; Trondl, Robert; Heffeter, Petra; Arion, Vladimir B.; Jakupec, Michael A.; Roller, Alexander; Galanski, Markus; Berger, Walter; Keppler, Bernhard K.
Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Journal of medicinal chemistry, 2009, 52, 5032-5043
1503671 CIFC16 H22 Ga N11 O4 S2P -19.3441; 9.7491; 12.9501
102.437; 95.239; 96.569
1136.26Kowol, Christian R.; Trondl, Robert; Heffeter, Petra; Arion, Vladimir B.; Jakupec, Michael A.; Roller, Alexander; Galanski, Markus; Berger, Walter; Keppler, Bernhard K.
Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Journal of medicinal chemistry, 2009, 52, 5032-5043
1503672 CIFC7 H9 N5 SP n a 2118.5732; 5.5273; 17.2799
90; 90; 90
1773.95Kowol, Christian R.; Trondl, Robert; Heffeter, Petra; Arion, Vladimir B.; Jakupec, Michael A.; Roller, Alexander; Galanski, Markus; Berger, Walter; Keppler, Bernhard K.
Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Journal of medicinal chemistry, 2009, 52, 5032-5043
1503673 CIFC28 H46 Fe2 N22 O13 S4C 1 2/c 19.2033; 23.0998; 21.2104
90; 92.473; 90
4505Kowol, Christian R.; Trondl, Robert; Heffeter, Petra; Arion, Vladimir B.; Jakupec, Michael A.; Roller, Alexander; Galanski, Markus; Berger, Walter; Keppler, Bernhard K.
Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Journal of medicinal chemistry, 2009, 52, 5032-5043
1503674 CIFC48 H44.5 N4 O20.25 S8P 1 21/n 112.6727; 30.0947; 13.5037
90; 96.832; 90
5113.5Wang, Kui; Guo, Dong-Sheng; Zhang, Hong-Qing; Li, Dong; Zheng, Xi-Long; Liu, Yu
Highly effective binding of viologens by p-sulfonatocalixarenes for the treatment of viologen poisoning.
Journal of medicinal chemistry, 2009, 52, 6402-6412
1503675 CIFC52 H65 N4 O26.5 S4P -113.699; 13.796; 15.189
88.402; 77.838; 81.671
2776.6Wang, Kui; Guo, Dong-Sheng; Zhang, Hong-Qing; Li, Dong; Zheng, Xi-Long; Liu, Yu
Highly effective binding of viologens by p-sulfonatocalixarenes for the treatment of viologen poisoning.
Journal of medicinal chemistry, 2009, 52, 6402-6412
1504341 CIFC21 H34 N2 O3C 1 2 119.155; 5.871; 19.432
90; 96.031; 90
2173.2Gomtsyan, Arthur; Bayburt, Erol K.; Schmidt, Robert G.; Surowy, Carol S.; Honore, Prisca; Marsh, Kennan C.; Hannick, Steven M.; McDonald, Heath A.; Wetter, Jill M.; Sullivan, James P.; Jarvis, Michael F.; Faltynek, Connie R.; Lee, Chih-Hung
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.
Journal of medicinal chemistry, 2008, 51, 392-395
1504342 CIFC20 H15 Cl N2 O5P 21 21 215.3438; 10.7546; 32.137
90; 90; 90
1846.9Crosignani, Stefano; Page, Patrick; Missotten, Marc; Colovray, Véronique; Cleva, Christophe; Arrighi, Jean-François; Atherall, John; Macritchie, Jackie; Martin, Thierry; Humbert, Yves; Gaudet, Marilène; Pupowicz, Doris; Maio, Maurizio; Pittet, Pierre-André; Golzio, Lucia; Giachetti, Claudio; Rocha, Cynthia; Bernardinelli, Gérald; Filinchuk, Yaroslav; Scheer, Alexander; Schwarz, Matthias K.; Chollet, André
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Journal of medicinal chemistry, 2008, 51, 2227-2243
1504343 CIFC20 H14 Cl F N2 O5P 21 21 215.32926; 10.77905; 31.3253
90; 90; 90
1799.46Crosignani, Stefano; Page, Patrick; Missotten, Marc; Colovray, Véronique; Cleva, Christophe; Arrighi, Jean-François; Atherall, John; Macritchie, Jackie; Martin, Thierry; Humbert, Yves; Gaudet, Marilène; Pupowicz, Doris; Maio, Maurizio; Pittet, Pierre-André; Golzio, Lucia; Giachetti, Claudio; Rocha, Cynthia; Bernardinelli, Gérald; Filinchuk, Yaroslav; Scheer, Alexander; Schwarz, Matthias K.; Chollet, André
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Journal of medicinal chemistry, 2008, 51, 2227-2243
1504344 CIFC19 H19 Cl2 N3 O3P -19.12; 10.251; 11.299
71.757; 74.66; 80.836
964.1Magedov, Igor V.; Manpadi, Madhuri; Ogasawara, Marcia A.; Dhawan, Adriana S.; Rogelj, Snezna; Van Slambrouck, Severine; Steelant, Wim F. A.; Evdokimov, Nikolai M.; Uglinskii, Pavel Y.; Elias, Eerik M.; Knee, Erica J.; Tongwa, Paul; Antipin, Mikhail Yu; Kornienko, Alexander
Structural simplification of bioactive natural products with multicomponent synthesis. 2. antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones.
Journal of medicinal chemistry, 2008, 51, 2561-2570
1504345 CIFC21 H23 N3 O2P -17.9246; 8.7859; 28.0323
87.074; 85.771; 73.203
1862.5Diaz, Philippe; Xu, Jijun; Astruc-Diaz, Fanny; Pan, Hao-Min; Brown, David L.; Naguib, Mohamed
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
Journal of medicinal chemistry, 2008, 51, 4932-4947
1504346 CIFC19 H31 Cl3 N2 OP 1 21 110.3558; 6.8232; 14.7816
90; 94.469; 90
1041.29Mahaney, Paige E.; Gavrin, Lori K.; Trybulski, Eugene J.; Stack, Gary P.; Vu, T. An; Cohn, Stephen T.; Ye, Fei; Belardi, Justin K.; Santilli, Arthur A.; Sabatucci, Joseph P.; Leiter, Jennifer; Johnston, Grace H.; Bray, Jenifer A.; Burroughs, Kevin D.; Cosmi, Scott A.; Leventhal, Liza; Koury, Elizabeth J.; Zhang, Yingru; Mugford, Cheryl A.; Ho, Douglas M.; Rosenzweig-Lipson, Sharon J; Platt, Brian; Smith, Valerie A.; Deecher, Darlene C.
Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.
Journal of medicinal chemistry, 2008, 51, 4038-4049
1504347 CIFC17 H28 Cl2 N3 O P RuP 1 n 16.6343; 20.033; 15.188
90; 97.73; 90
2000.2Casini, Angela; Gabbiani, Chiara; Sorrentino, Francesca; Rigobello, Maria Pia; Bindoli, Alberto; Geldbach, Tilmann J.; Marrone, Alessandro; Re, Nazzareno; Hartinger, Christian G.; Dyson, Paul J.; Messori, Luigi
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.
Journal of medicinal chemistry, 2008, 51, 6773-6781
1505016 CIFC14 H14 Cl4 Cu2 N10P 1 21/a 18.346; 14.28; 8.376
90; 93.43; 90
996.5Tardito, Saverio; Bussolati, Ovidio; Maffini, Monica; Tegoni, Matteo; Giannetto, Marco; Dall'asta, Valeria; Franchi-Gazzola, Renata; Lanfranchi, Maurizio; Pellinghelli, Maria Angela; Mucchino, Claudio; Mori, Giovanni; Marchio, Luciano
Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells.
Journal of medicinal chemistry, 2007, 50, 1916-1924
1505017 CIFC20 H21 Cl4 Cu2 N10 O1.5 S2P -18.827; 10.796; 16.59
72.92; 85.5; 66.58
1385.4Tardito, Saverio; Bussolati, Ovidio; Maffini, Monica; Tegoni, Matteo; Giannetto, Marco; Dall'asta, Valeria; Franchi-Gazzola, Renata; Lanfranchi, Maurizio; Pellinghelli, Maria Angela; Mucchino, Claudio; Mori, Giovanni; Marchio, Luciano
Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells.
Journal of medicinal chemistry, 2007, 50, 1916-1924
1505018 CIFC9 H11 Cl2 Cu N5 SP -18.649; 9.313; 9.371
68.69; 71.86; 79.27
666Tardito, Saverio; Bussolati, Ovidio; Maffini, Monica; Tegoni, Matteo; Giannetto, Marco; Dall'asta, Valeria; Franchi-Gazzola, Renata; Lanfranchi, Maurizio; Pellinghelli, Maria Angela; Mucchino, Claudio; Mori, Giovanni; Marchio, Luciano
Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells.
Journal of medicinal chemistry, 2007, 50, 1916-1924
1505019 CIFC14 H19.5 Cl2 N Na O6.75P 1 21 19.554; 39.491; 9.8412
90; 90.729; 90
3712.75Llinàs, Antonio; Burley, Jonathan C.; Box, Karl J.; Glen, Robert C.; Goodman, Jonathan M.
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
Journal of medicinal chemistry, 2007, 50, 979-983
1505020 CIFC24 H39.5 Cl N8 O8.25 Pt SP 1 21 110.509; 31.892; 10.564
90; 117.63; 90
3137Guddneppanavar, Rajsekhar; Choudhury, Jayati Roy; Kheradi, Alexander R.; Steen, Bartlett D.; Saluta, Gilda; Kucera, Gregory L.; Day, Cynthia S.; Bierbach, Ulrich
Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Journal of medicinal chemistry, 2007, 50, 2259-2263
1505021 CIFC21 H33 Cl N8 O7 Pt SP -110.6463; 10.9812; 13.1259
90.642; 99.622; 113.788
1379.1Guddneppanavar, Rajsekhar; Choudhury, Jayati Roy; Kheradi, Alexander R.; Steen, Bartlett D.; Saluta, Gilda; Kucera, Gregory L.; Day, Cynthia S.; Bierbach, Ulrich
Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Journal of medicinal chemistry, 2007, 50, 2259-2263
1505022 CIFC24 H37 Cl N8 O6 Pt SP -17.266; 11.8032; 17.193
95.598; 92.629; 94.082
1461.7Guddneppanavar, Rajsekhar; Choudhury, Jayati Roy; Kheradi, Alexander R.; Steen, Bartlett D.; Saluta, Gilda; Kucera, Gregory L.; Day, Cynthia S.; Bierbach, Ulrich
Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Journal of medicinal chemistry, 2007, 50, 2259-2263
1505023 CIFC28 H37 Cl N8 O10 Pt SP -114.4746; 18.7922; 19.543
103.44; 98.838; 95.471
5061.2Guddneppanavar, Rajsekhar; Choudhury, Jayati Roy; Kheradi, Alexander R.; Steen, Bartlett D.; Saluta, Gilda; Kucera, Gregory L.; Day, Cynthia S.; Bierbach, Ulrich
Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Journal of medicinal chemistry, 2007, 50, 2259-2263
1505024 CIFC68 H58 B Cl N4 RuP 1 21/c 110.6994; 29.8522; 18.8571
90; 116.835; 90
5374.4Vock, Carsten A.; Ang, Wee Han; Scolaro, Claudine; Phillips, Andrew D.; Lagopoulos, Lucienne; Juillerat-Jeanneret, Lucienne; Sava, Gianni; Scopelliti, Rosario; Dyson, Paul J.
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Journal of medicinal chemistry, 2007, 50, 2166-2175
1505025 CIFC27 H26 Cl2 N2 RuP 1 21/c 114.34; 12.4234; 15.156
90; 117.502; 90
2394.9Vock, Carsten A.; Ang, Wee Han; Scolaro, Claudine; Phillips, Andrew D.; Lagopoulos, Lucienne; Juillerat-Jeanneret, Lucienne; Sava, Gianni; Scopelliti, Rosario; Dyson, Paul J.
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Journal of medicinal chemistry, 2007, 50, 2166-2175
1505026 CIFC35 H37 Cl2 N3 O4 RuP 1 21/c 112.658; 14.916; 17.958
90; 102.445; 90
3310.9Vock, Carsten A.; Ang, Wee Han; Scolaro, Claudine; Phillips, Andrew D.; Lagopoulos, Lucienne; Juillerat-Jeanneret, Lucienne; Sava, Gianni; Scopelliti, Rosario; Dyson, Paul J.
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Journal of medicinal chemistry, 2007, 50, 2166-2175
1505027 CIFC22 H29 N O6P 1 21 114.443; 5.797; 15.243
90; 115.4; 90
1152.9Saquib, Mohammad; Gupta, Manish K.; Sagar, Ram; Prabhakar, Yenamandra S.; Shaw, Arun K.; Kumar, Rishi; Maulik, Prakas R.; Gaikwad, Anil N.; Sinha, Sudhir; Srivastava, Anil K.; Chaturvedi, Vinita; Srivastava, Ranjana; Srivastava, Brahm S.
C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.
Journal of medicinal chemistry, 2007, 50, 2942-2950
1505028 CIFC23 H36 Cl Cu N5 O8P b c a21.134; 10.7258; 23.111
90; 90; 90
5238.8Sprague, Jennifer E.; Peng, Yijie; Fiamengo, Ashley L.; Woodin, Katrina S.; Southwick, Evan A.; Weisman, Gary R.; Wong, Edward H.; Golen, James A.; Rheingold, Arnold L.; Anderson, Carolyn J.
Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents.
Journal of medicinal chemistry, 2007, 50, 2527-2535
1505029 CIFC22 H27 N3 O5P 1 21 16.6883; 5.6677; 27.611
90; 95.9; 90
1041.1Robins, Morris J.; Nowak, Ireneusz; Rajwanshi, Vivek K.; Miranda, Karl; Cannon, John F.; Peterson, Matt A.; Andrei, Graciela; Snoeck, Robert; De Clercq, Erik; Balzarini, Jan
Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core.
Journal of medicinal chemistry, 2007, 50, 3897-3905
1505030 CIFC21 H24 N2 O5P 1 21 16.6665; 5.7707; 25.533
90; 95.15; 90
978.3Robins, Morris J.; Nowak, Ireneusz; Rajwanshi, Vivek K.; Miranda, Karl; Cannon, John F.; Peterson, Matt A.; Andrei, Graciela; Snoeck, Robert; De Clercq, Erik; Balzarini, Jan
Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core.
Journal of medicinal chemistry, 2007, 50, 3897-3905
1505031 CIFC23 H32 O8P 21 21 216.3428; 10.563; 31.962
90; 90; 90
2141.4Simpson, Denise S.; Katavic, Peter L.; Lozama, Anthony; Harding, Wayne W.; Parrish, Damon; Deschamps, Jeffrey R.; Dersch, Christina M.; Partilla, John S.; Rothman, Richard B.; Navarro, Hernan; Prisinzano, Thomas E.
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
Journal of medicinal chemistry, 2007, 50, 3596-3603
1505032 CIFC30 H48 N2 O3P 16.135; 6.77; 17.17
92.3; 97.87; 99.35
695.6Sauvaître, Thibault; Barlier, Mireille; Herlem, Denyse; Gresh, Nohad; Chiaroni, Angèle; Guenard, Daniel; Guillou, Catherine
New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.
Journal of medicinal chemistry, 2007, 50, 5311-5323
1505033 CIFC28 H35 N O6P 21 21 218.6763; 14.897; 20.9747
90; 90; 90
2711Vyavahare, Vinod P.; Chakraborty, Chaitali; Maity, Biswanath; Chattopadhyay, Subrata; Puranik, Vedavati G.; Dhavale, Dilip D.
Synthesis of 1-deoxy-1-hydroxymethyl- and 1-deoxy-1-epi-hydroxymethyl castanospermine as new potential immunomodulating agents.
Journal of medicinal chemistry, 2007, 50, 5519-5523
1505034 CIFC9 H17 N O4P 1 21 17.1718; 6.9079; 10.864
90; 107.338; 90
513.77Vyavahare, Vinod P.; Chakraborty, Chaitali; Maity, Biswanath; Chattopadhyay, Subrata; Puranik, Vedavati G.; Dhavale, Dilip D.
Synthesis of 1-deoxy-1-hydroxymethyl- and 1-deoxy-1-epi-hydroxymethyl castanospermine as new potential immunomodulating agents.
Journal of medicinal chemistry, 2007, 50, 5519-5523
1505035 CIFC10 H4 O2 S2P 1 21/c 18.96; 14.8156; 6.7569
90; 102.962; 90
874.11Hyatt, Janice L.; Wadkins, Randy M.; Tsurkan, Lyudmila; Hicks, Latorya D.; Hatfield, M. Jason; Edwards, Carol C.; Ross, 2nd, Charles R; Cantalupo, Stephanie A.; Crundwell, Guy; Danks, Mary K.; Guy, R. Kip; Potter, Philip M.
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
Journal of medicinal chemistry, 2007, 50, 5727-5734
1505036 CIFC12 H26 Cl2 N2 O9 PtP n a 2123.5231; 10.6395; 8.1822
90; 90; 90
2047.79Reithofer, Michael R.; Valiahdi, Seied M.; Jakupec, Michael A.; Arion, Vladimir B.; Egger, Alexander; Galanski, Markus; Keppler, Bernhard K.
Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.
Journal of medicinal chemistry, 2007, 50, 6692-6699
1505037 CIFC22 H17 N5 O2P 1 21/c 110.8951; 20.05; 8.6412
90; 90.16; 90
1887.6Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505038 CIFC35 H36 Cl2 N4 O2 RuP 1 c 19.872; 9.6208; 17.434
90; 104.05; 90
1606.3Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505039 CIFC36 H43 Cl2 N5 O4 RuP -112.2485; 12.6418; 14.3132
95.421; 108.122; 118.054
1780.65Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505040 CIFC35 H36 Cl2 N4 O2 OsP 1 c 19.876; 9.6263; 17.46
90; 104.32; 90
1608.3Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505041 CIFC130 H133 Br4 Cl8 N16 O3.5 Os4P -113.8319; 14.1376; 18.3912
98.511; 107.338; 102.012
3271.8Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505042 CIFC35.9 H42.95 Cl2 N5 O4.08 OsP -112.2836; 12.6756; 14.2592
95.491; 107.998; 118.072
1784.59Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505043 CIFC32 H32.5 Cl2 N4 O0.25 OsP -113.958; 14.0949; 18.3531
96.749; 108.022; 102.05
3292.9Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505044 CIFC36 H45 Cl2 N5 O5 RuP 1 21/c 110.771; 25.04; 13.238
90; 91.84; 90
3568.5Schmid, Wolfgang F.; John, Roland O.; Mühlgassner, Gerhard; Heffeter, Petra; Jakupec, Michael A.; Galanski, Markus; Berger, Walter; Arion, Vladimir B.; Keppler, Bernhard K.
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
Journal of medicinal chemistry, 2007, 50, 6343-6355
1505680 CIFC23 H30 O7P 1 21 18.8996; 12.0769; 10.5206
90; 90.695; 90
1130.67Luo, Weiming; Yu, Qian-Sheng; Kulkarni, Santosh S.; Parrish, Damon A.; Holloway, Harold W.; Tweedie, David; Shafferman, Avigdor; Lahiri, Debomoy K.; Brossi, Arnold; Greig, Nigel H.
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
Journal of medicinal chemistry, 2006, 49, 2174-2185
1505681 CIFC45 H58 Br2 N2 O15P 21 21 2111.054; 20.276; 21.194
90; 90; 90
4750Jiang, Yi; Alcaraz, Ana A.; Chen, Jian-Min; Kobayashi, Hisayoshi; Lu, Yang J.; Snyder, James P.
Diastereomers of dibromo-7-epi-10-deacetylcephalomannine: crowded and cytotoxic taxanes exhibit halogen bonds.
Journal of medicinal chemistry, 2006, 49, 1891-1899
1505682 CIFC27 H25 Au N O5 P SP -110.218; 12.489; 12.62
106.208; 112.512; 104.97
1302Gunatilleke, Shamila S.; Barrios, Amy M.
Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation.
Journal of medicinal chemistry, 2006, 49, 3933-3937
1505683 CIFC18 H28 Cl2 N4 O RuP -17.8903; 9.5995; 14.1039
78.964; 87.859; 86.905
1046.59Vock, Carsten A.; Scolaro, Claudine; Phillips, Andrew D.; Scopelliti, Rosario; Sava, Gianni; Dyson, Paul J.
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Journal of medicinal chemistry, 2006, 49, 5552-5561
1505684 CIFC24 H38 Cl2 N4 RuP -18.563; 13.044; 13.243
110.87; 98.93; 95.91
1345.2Vock, Carsten A.; Scolaro, Claudine; Phillips, Andrew D.; Scopelliti, Rosario; Sava, Gianni; Dyson, Paul J.
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Journal of medicinal chemistry, 2006, 49, 5552-5561
1505685 CIFC18 H24 B2 F8 N6 RuP 1 21/c 18.4268; 13.5307; 19.9593
90; 91.305; 90
2275.2Vock, Carsten A.; Scolaro, Claudine; Phillips, Andrew D.; Scopelliti, Rosario; Sava, Gianni; Dyson, Paul J.
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Journal of medicinal chemistry, 2006, 49, 5552-5561
1505686 CIFC34 H52 Cl4 N4 Ru2P -112.4321; 12.9605; 13.0867
90.149; 117.791; 90.948
1865Vock, Carsten A.; Scolaro, Claudine; Phillips, Andrew D.; Scopelliti, Rosario; Sava, Gianni; Dyson, Paul J.
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Journal of medicinal chemistry, 2006, 49, 5552-5561
1505687 CIFC36 H34 B Cl N4 RuP 1 21/n 113.3895; 12.5339; 18.671
90; 104.039; 90
3039.8Vock, Carsten A.; Scolaro, Claudine; Phillips, Andrew D.; Scopelliti, Rosario; Sava, Gianni; Dyson, Paul J.
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Journal of medicinal chemistry, 2006, 49, 5552-5561
1506344 CIFC19 H29 N O5P 1 21 16.866; 19.559; 7.04
90; 97.132; 90
938.1Simoni, Daniele; Rossi, Marcello; Bertolasi, Valerio; Roberti, Marinella; Pizzirani, Daniela; Rondanin, Riccardo; Baruchello, Riccardo; Invidiata, Francesco Paolo; Tolomeo, Manlio; Grimaudo, Stefania; Merighi, Stefania; Varani, Katia; Gessi, Stefania; Borea, Pier Andrea; Marino, Silvia; Cavallini, Sabrina; Bianchi, Clementina; Siniscalchi, Anna
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
Journal of medicinal chemistry, 2005, 48, 3337-3343
1506345 CIFC30 H32 Cl3 N8 O2 RuC 1 c 117.681; 11.082; 16.738
90; 102.46; 90
3202.4Jakupec, Michael A.; Reisner, Erwin; Eichinger, Anna; Pongratz, Martina; Arion, Vladimir B.; Galanski, Markus; Hartinger, Christian G.; Keppler, Bernhard K.
Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential.
Journal of medicinal chemistry, 2005, 48, 2831-2837
1506346 CIFC34 H36 Cl2 N8 O2 RuP -110.891; 13.279; 14.399
65.66; 69.04; 68.36
1710.8Jakupec, Michael A.; Reisner, Erwin; Eichinger, Anna; Pongratz, Martina; Arion, Vladimir B.; Galanski, Markus; Hartinger, Christian G.; Keppler, Bernhard K.
Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential.
Journal of medicinal chemistry, 2005, 48, 2831-2837
1506347 CIFC21 H28 O3P 21 21 2110.405; 16.508; 20.85
90; 90; 90
3581.3Veleiro, Adriana S.; Pecci, Adali; Monteserín, María C; Baggio, Ricardo; Garland, María T; Lantos, Carlos P.; Burton, Gerardo
6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity.
Journal of medicinal chemistry, 2005, 48, 5675-5683
1506348 CIFC21 H28 O2 SP 21 21 2111.153; 12.65; 12.94
90; 90; 90
1825.6Veleiro, Adriana S.; Pecci, Adali; Monteserín, María C; Baggio, Ricardo; Garland, María T; Lantos, Carlos P.; Burton, Gerardo
6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity.
Journal of medicinal chemistry, 2005, 48, 5675-5683
1506349 CIFC14 H16 Cu Fe N10 O5 SP 1 21/n 113.157; 13.641; 14.205
90; 115.98; 90
2291.8Belicchi-Ferrari, Marisa; Bisceglie, Franco; Casoli, Claudio; Durot, Stéphanie; Morgenstern-Badarau, Irène; Pelosi, Giorgio; Pilotti, Elisabetta; Pinelli, Silvana; Tarasconi, Pieralberto
Copper(II) and cobalt(III) pyridoxal thiosemicarbazone complexes with nitroprusside as counterion: syntheses, electronic properties, and antileukemic activity.
Journal of medicinal chemistry, 2005, 48, 1671-1675
1506350 CIFC23 H34 Cu2 Fe N14 O11 S2P 1 21/n 113.946; 7.163; 18.389
90; 93.37; 90
1833.8Belicchi-Ferrari, Marisa; Bisceglie, Franco; Casoli, Claudio; Durot, Stéphanie; Morgenstern-Badarau, Irène; Pelosi, Giorgio; Pilotti, Elisabetta; Pinelli, Silvana; Tarasconi, Pieralberto
Copper(II) and cobalt(III) pyridoxal thiosemicarbazone complexes with nitroprusside as counterion: syntheses, electronic properties, and antileukemic activity.
Journal of medicinal chemistry, 2005, 48, 1671-1675
1506351 CIFC41 H60 Co2 Fe N22 O17 S4P -115.278; 13.533; 7.977
84.4; 76.78; 77.22
1563.9Belicchi-Ferrari, Marisa; Bisceglie, Franco; Casoli, Claudio; Durot, Stéphanie; Morgenstern-Badarau, Irène; Pelosi, Giorgio; Pilotti, Elisabetta; Pinelli, Silvana; Tarasconi, Pieralberto
Copper(II) and cobalt(III) pyridoxal thiosemicarbazone complexes with nitroprusside as counterion: syntheses, electronic properties, and antileukemic activity.
Journal of medicinal chemistry, 2005, 48, 1671-1675
1506352 CIFC28 H38 N O6 PP 16.413; 13.141; 17.092
82.02; 86.3; 76.29
1385.1Albert, Rainer; Hinterding, Klaus; Brinkmann, Volker; Guerini, Danilo; Müller-Hartwieg, Constanze; Knecht, Helmut; Simeon, Corinne; Streiff, Markus; Wagner, Trixie; Welzenbach, Karl; Zécri, Frédéric; Zollinger, Markus; Cooke, Nigel; Francotte, Eric
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.
Journal of medicinal chemistry, 2005, 48, 5373-5377
1506353 CIFC23 H21 F4 N O4P -18.8822; 9.7444; 12.9675
76.306; 72.48; 89.873
1036.98Deng, Bo-Liang; Hartman, Tracy L.; Buckheit, Jr, Robert W; Pannecouque, Christophe; De Clercq, Erik; Fanwick, Phillip E.; Cushman, Mark
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors.
Journal of medicinal chemistry, 2005, 48, 6140-6155
1506354 CIFC9 H8 I N O2P 1 21/c 14.1515; 16.0162; 14.1406
90; 97.411; 90
932.37Deng, Bo-Liang; Hartman, Tracy L.; Buckheit, Jr, Robert W; Pannecouque, Christophe; De Clercq, Erik; Fanwick, Phillip E.; Cushman, Mark
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors.
Journal of medicinal chemistry, 2005, 48, 6140-6155
1506355 CIFC22 H32 Cl2 N2 O6 PtP 1 21/c 17.7485; 18.294; 18.356
90; 92.129; 90
2600.2Ang, Wee Han; Pilet, Sébastien; Scopelliti, Rosario; Bussy, François; Juillerat-Jeanneret, Lucienne; Dyson, Paul J.
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
Journal of medicinal chemistry, 2005, 48, 8060-8069
1506356 CIFC26 H36 Cl2 N2 O6 PtI 1 2/a 123.951; 7.8455; 32.732
90; 110.353; 90
5766.6Ang, Wee Han; Pilet, Sébastien; Scopelliti, Rosario; Bussy, François; Juillerat-Jeanneret, Lucienne; Dyson, Paul J.
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
Journal of medicinal chemistry, 2005, 48, 8060-8069
1506357 CIFC24 H30 Cl2 N4 O6 PtP -17.8196; 12.2969; 16.4366
81.492; 77.063; 88.498
1523.4Ang, Wee Han; Pilet, Sébastien; Scopelliti, Rosario; Bussy, François; Juillerat-Jeanneret, Lucienne; Dyson, Paul J.
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
Journal of medicinal chemistry, 2005, 48, 8060-8069
1506358 CIFC20 H24 Cl2 N2 O9 PtP -18.9038; 12.4327; 12.8543
62.59; 82.906; 72.039
1201.4Ang, Wee Han; Pilet, Sébastien; Scopelliti, Rosario; Bussy, François; Juillerat-Jeanneret, Lucienne; Dyson, Paul J.
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
Journal of medicinal chemistry, 2005, 48, 8060-8069

Left arrow Left arrow First | Left arrow Previous 100 | of 3 | Next 100 Blue right arrow | Last Blue right arrow Blue right arrow | Display 5 20 50 100 200 300 500 1000 entries per page

Back to the search form
Your own data is not in the COD? Deposit it, thanks!